Diferansiye tiroit kanserlerinin takibinde tiroglobulin otoantikorunun önemi

Kgün A; Yazıcı B; Erdim Ö; Yararbaş Ü; Özkılıç H

EN TR

The use of TgAb as a marker in differentiated thyroid cancer after ablation theraphy

Abstract

Introduction: Aim was to evaluate thyroglobulin antibodies (TgAbs) variations before and after ablation and correlate thyroglobulin (Tg) and TgAbs levels to the outcome of disease in differentiated thyroid carcinoma (DTC) Material and Methods: We focused on 27 patients (22 female, 5 male, age range 24-70 years, 25 papillary and 2 follicular carcinoma) who had high levels of TgAbs in the post-surgical period. The follow-up was ranging form 30 to 88 months (mean: 45±16 months). The amount of I-131 administered was 75-175 mCi (mean 104.63±20,84 mCi ) Results: Successful ablation was achieved in 25 of 27 (92.5 %) patients. When pre and post ablation values were compared TgAb and Tg levels regressed significantly (Tg 1.66±3.70 ng/ml 0.19±0.25 ng/ml p

Keywords

Thyroglobulin, differentiated thyroid carcinoma, thyroglobulin autoantibody

Ayrıntılar

Birincil Dil

Türkçe

Konular

-

Bölüm

-

Yazarlar

Kgün A

Yazıcı B

Erdim Ö

Yararbaş Ü

Özkılıç H

Yayımlanma Tarihi

1 Mart 2009

Gönderilme Tarihi

1 Mart 2009

Kabul Tarihi

-

Yayımlandığı Sayı

Yıl 1970 Cilt: 48 Sayı: 1

IZ

https://izlik.org/JA49CC93KW

Kaynak Göster

RIS / Bibtex

Vancouver

1.Kgün A, Yazıcı B, Erdim Ö, Yararbaş Ü, Özkılıç H. Diferansiye tiroit kanserlerinin takibinde tiroglobulin otoantikorunun önemi. ETD [Internet]. 01 Mart 2009;48(1):19-22. Erişim adresi: https://izlik.org/JA49CC93KW

The use of TgAb as a marker in differentiated thyroid cancer after ablation theraphy

Abstract

Keywords